Harrison SA - Search Results

1

Practice patterns in NAFLD and NASH: real life differs from published guidelines.

Rinella ME, Lominadze Z, Loomba R, Charlton M, Neuschwander-Tetri BA, Caldwell SH, Kowdley K, Harrison SA. Rinella ME, et al. Among authors: harrison sa. Therap Adv Gastroenterol. 2016 Jan;9(1):4-12. doi: 10.1177/1756283X15611581. Therap Adv Gastroenterol. 2016. PMID: 26770262 Free PMC article.

2

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Harrison SA, Neuschwander-Tetri BA. Harrison SA, et al. Clin Liver Dis. 2004 Nov;8(4):861-79, ix. doi: 10.1016/j.cld.2004.06.008. Clin Liver Dis. 2004. PMID: 15464659 Review.

3

Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C.

Harrison SA, Brunt EM, Qazi RA, Oliver DA, Neuschwander-Tetri BA, Di Bisceglie AM, Bacon BR. Harrison SA, et al. Clin Gastroenterol Hepatol. 2005 Jun;3(6):604-9. doi: 10.1016/s1542-3565(05)00246-6. Clin Gastroenterol Hepatol. 2005. PMID: 15952103

4

Impact of obesity on treatment of chronic hepatitis C.

Charlton MR, Pockros PJ, Harrison SA. Charlton MR, et al. Among authors: harrison sa. Hepatology. 2006 Jun;43(6):1177-86. doi: 10.1002/hep.21239. Hepatology. 2006. PMID: 16729327 Review.

5

Diagnosis and therapy of nonalcoholic steatohepatitis.

Torres DM, Harrison SA. Torres DM, et al. Among authors: harrison sa. Gastroenterology. 2008 May;134(6):1682-98. doi: 10.1053/j.gastro.2008.02.077. Gastroenterology. 2008. PMID: 18471547 Review.

6

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Harrison SA, et al. Hepatology. 2009 Jan;49(1):80-6. doi: 10.1002/hep.22575. Hepatology. 2009. PMID: 19053049 Clinical Trial.

7

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Williams CD, et al. Among authors: harrison sa. Gastroenterology. 2011 Jan;140(1):124-31. doi: 10.1053/j.gastro.2010.09.038. Epub 2010 Sep 19. Gastroenterology. 2011. PMID: 20858492

8

Current status of therapy in nonalcoholic Fatty liver disease.

McNear S, Harrison SA. McNear S, et al. Among authors: harrison sa. Therap Adv Gastroenterol. 2009 Jan;2(1):29-43. doi: 10.1177/1756283X08100327. Therap Adv Gastroenterol. 2009. PMID: 21180532 Free PMC article.

9

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases. Bacon BR, et al. Hepatology. 2011 Jul;54(1):328-43. doi: 10.1002/hep.24330. Hepatology. 2011. PMID: 21452290 Free PMC article. No abstract available.

10

Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease.

Touzin NT, Bush KN, Williams CD, Harrison SA. Touzin NT, et al. Among authors: harrison sa. Therap Adv Gastroenterol. 2011 May;4(3):169-76. doi: 10.1177/1756283X11402118. Therap Adv Gastroenterol. 2011. PMID: 21694801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters